Real time high-resolution micro-ultrasound guided biopsy: A new strategy to overcome systematic prostate biopsy

Real time high-resolution micro-ultrasound guided biopsy: A new strategy to overcome systematic prostate biopsy

Dades bibliogràfiques
Autors principals:	M. Paciotti, D. Maffei, P.P. Avolio, V. Fasulo, A.R. Saita, P. Casale, R. Hurle, M. Lazzeri, N.M. Buffi, G.F. Guazzoni, L. Giovanni
Format:	Article
Idioma:	English
Publicat:	Elsevier 2020-11-01
Col·lecció:	European Urology Open Science
Accés en línia:	http://www.sciencedirect.com/science/article/pii/S2666168320360730

Ítems similars

Micro-ultrasound guided and MRI-targeted prostate biopsies for clinically significant prostate cancer diagnosis in the initial biopsy setting a cohort of biopsy-naive patients
per: D. Maffei, et al.
Publicat: (2020-10-01)

Diagnostic performance of micro-ultrasound prostate biopsies in patients undergoing mpMRI-fusion biopsies
per: D. Maffei, et al.
Publicat: (2020-07-01)

Micro-ultrasound guided prostate biopsies for clinically significant prostate cancer diagnosis in a cohort of biopsy-naive patients with mpMRI
per: D. Maffei, et al.
Publicat: (2020-11-01)

Diagnostic performance of micro-ultrasound prostate biopsies in patients undergoing mpMRI- fusion biopsie
per: D. Maffei, et al.
Publicat: (2020-11-01)

Clincally signicant prostate cancer diagnosis by micro-ultrasound guided prostate biopsies: A real-life single center experience
per: P.P. Avolio, et al.
Publicat: (2020-11-01)

Diagnostic performance of micro-ultrasound in patients under active surveillance for low-risk prostate cancer
per: A. Uleri, et al.
Publicat: (2020-10-01)

Diagnostic performance of micro-ultrasound in patients under active surveillance for low-risk prostate cancer
per: D. Maffei, et al.
Publicat: (2020-11-01)

The use of 29 MHz transrectal micro ultrasound to stratify the presence of prostate cancer in patients with an equivocal mpMRI: A single institutional analysis
per: P.P. Avolio, et al.
Publicat: (2020-11-01)

The utility of micro-ultrasound in patients under active surveillance for low-risk prostate cancer: A PRIAS study extension
per: D. Maffei, et al.
Publicat: (2020-07-01)

A Propensity Score–matched Comparison of Micro-ultrasound–guided Transrectal and Magnetic Resonance Imaging/Transrectal Ultrasound Fusion-guided Transperineal Prostate Biopsies for Detection of Clinically Significant Prostate Cancer
per: Andrea Piccolini, et al.
Publicat: (2024-11-01)

The use OF 29 MHz transrectal micro ultrasound for the local staging of prostate cancer: A single institutional analysis
per: F. Regis, et al.
Publicat: (2020-11-01)

Oncological long-term safety and pathological outcome evaluation for patients under active surveillance for recurrent low-risk non-muscle invasive bladder cancer: Result from bladder cancer Italian active surveillance (BIAS) project
per: N. Frego, et al.
Publicat: (2020-07-01)

Laser lithotripter settings according to endoscopic view: How can we optimise the outcome? A simple way to optimise the treatment strategy
per: N. Frego, et al.
Publicat: (2020-07-01)

Oncological long-term safety and pathological outcome evaluation for patients under active surveillance for recurrent low-risk non-muscle invasive bladder cancer: result from Bladder Cancer Italian Active Surveillance (BIAS) project
per: R. Contieri, et al.
Publicat: (2020-10-01)

Update on the potential role of micro-ultrasound in the differentiation between muscle-invasive and non-muscle invasive bladder cancer
per: A. Uleri, et al.
Publicat: (2020-10-01)

TMPRSS2: ERG expression in prostate cancer: Imaging and clinico-pathological correlations
per: V. Fasulo, et al.
Publicat: (2020-10-01)

Head-to-head comparison between micro-ultrasound and MRI in the differentiation between muscle-invasive and non-muscle invasive bladder cancer: Results from the bladder microUS versus MRI cancer imaging staging study (BUS-MISS) protocol
per: P. Diana, et al.
Publicat: (2020-07-01)

Post-Biopsy Cell-Free DNA From Blood: An Open Window on Primary Prostate Cancer Genetics and Biology
per: Marinella Corbetta, et al.
Publicat: (2021-05-01)

A Comparative Evaluation of Multiparametric Magnetic Resonance Imaging and Micro-Ultrasound for the Detection of Clinically Significant Prostate Cancer in Patients with Prior Negative Biopsies
per: Edoardo Beatrici, et al.
Publicat: (2024-03-01)

Long-term Follow-up After En Bloc Transurethral Resection of Non–muscle-invasive Bladder Cancer: Results from a Single-center Experience
per: Marco Paciotti, et al.
Publicat: (2021-04-01)

Targeted 11C–choline PET-CT/TRUS software fusion-guided prostate biopsy in men with persistently elevated PSA and negative mpMRI after previous negative biopsy
per: Massimo Lazzeri, et al.
Publicat: (2017-11-01)

Multi-institutional retrospective validation of the the Simplified PADUA REnal (SPARE) nephromatry system for the prediction of potential morbidity of nephron-sparing surgery for renal masses
per: P. Diana, et al.
Publicat: (2020-10-01)

Prospective evaluation of the role of imaging techniques and TMPRSS2:ERG mutation for the diagnosis of clinically significant prostate cancer
per: Massimo Lazzeri, et al.
Publicat: (2022-09-01)

Saturation target biopsy can overcome the learning curve of magnetic resonance imaging/ultrasound fusion biopsy of the prostate
per: Po-Fan Hsieh, et al.
Publicat: (2022-05-01)

Clinical performance of Xpert Bladder Cancer (BC) Monitor, a mRNA-based urine test, in Active Surveillance (AS) patients with recurrent Non-Muscle Invasive Bladder Cancer (NMIBC): Results from the Bladder Cancer Italian Active Surveillance (BIAS) project
per: R. Hurle, et al.
Publicat: (2020-07-01)

Xpert Bladder Cancer Monitor May Avoid Cystoscopies in Patients Under “Active Surveillance” for Recurrent Bladder Cancer (BIAS Project): Longitudinal Cohort Study
per: Vittorio Fasulo, et al.
Publicat: (2022-01-01)

Transrectal ultrasound and needle biopsy of the prostate
per: Tomaž Smrkolj
Publicat: (2016-01-01)

Do delays in prostate cancer treatment change survival outcomes?
per: M. Paciotti, et al.
Publicat: (2020-10-01)

Is the periprostatic anesthetic blockade advantageous in ultrasound-guided prostate biopsy?
per: André P. Vanni, et al.
Publicat: (2004-04-01)

Transrectal ultrasound prostate biopsies - if not fluoroquinolone, what else?
per: R. Rodrigues Fonseca, et al.
Publicat: (2020-07-01)

Prostate “Mapeo” for cancer diagnosis: The Madrid protocol. Transperineal prostate biopsies combining Micro-ultrasound and mpMRI fusion biopsy.
per: M.E. Rodríguez Socarrás, et al.
Publicat: (2020-01-01)

Prostate mapping for cancer diagnosis: The Madrid protocol. Transperineal prostate biopsies combining micro-ultrasound and mpMRI fusion biopsy
per: M.E. Rodríguez Socarrás, et al.
Publicat: (2020-07-01)

Male awareness of prostate cancer risk remains poor in relatives of women with germline variants in DNA‐repair genes
per: Vittorio Fasulo, et al.
Publicat: (2023-11-01)

Magnetic Resonance Imaging–targeted Prostate Biopsy Compared with Systematic Prostate Biopsy in Biopsy-naïve Patients with Suspected Prostate Cancer
per: Nicolette G. Alkema, et al.
Publicat: (2022-10-01)

MRI - ultrasound fusion guided biopsy of the prostate: lesion volume as a predictor of cancer in patients with repeat biopsies
per: Scott Alan Blaine, et al.
Publicat: (2019-01-01)

FUSION PROSTATE BIOPSY IN PATIENTS WITH PREVIOUS NEGATIVE STANDARD PROSTATE BIOPSY
per: A. A. Keln, et al.
Publicat: (2018-01-01)

Complications of Transrectal Prostate Biopsy
per: Cech P., et al.
Publicat: (2014-05-01)

The future perspectives in transrectal prostate ultrasound guided biopsy
per: Sung Il Hwang, et al.
Publicat: (2014-12-01)

Complications of ultrasound-guided needle biopsy of the prostate in the dog
per: Ali Rezaie, et al.
Publicat: (2007-11-01)

Strategies for prevention of ultrasound-guided prostate biopsy infections
per: Lu DD, et al.
Publicat: (2016-07-01)